COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner. - Jiang GB; Fang HY; Tao DY; Chen XP; Cao FL (European review for medical and pharmacological sciences, 2019)